The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Adolescents, Schizophrenia, risperidone
Eligibility Criteria
Inclusion Criteria: Subjects will be eligible for study enrollment if they: are adolescents between the ages of 13 and 17 years have a confirmed diagnosis of schizophrenia and are suffering from an acute episode provide their assent and parental informed consent to participate are otherwise relatively healthy on the basis of a medical and physical examination and are able to be in-patients for approximately 2 weeks. Exclusion Criteria: Subjects will be excluded from the study if they: meet the criteria for psychiatric disorders other than schizophrenia have moderate or severe mental retardation fail to respond to treatment with at least two typical or atypical antipsychotics have a history of substance dependence within the 3 months before screening are considered at risk for suicidal or violent behavior have a seizure disorder have a history of neuroleptic malignant syndrome, similar encephalopathic syndrome, or tardive dyskinesia or receive prohibited medication within a specified period before screening.